secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inspire Medical Systems, Inc. (INSP)
CIK:        0001609550
Form:       8-K
Filed at:   2024-07-29T23:59:59+00:00
Accession:  0001609550-24-000034
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Inspire Medical pre-announces Q2 revenue $195.9M (+30% YoY), raises 2024 guidance to $788-798M
--------------------------------------------------------------------------------

- Q2 revenue $195.9M, up 30% YoY; US revenue $187.8M (+30%), OUS $8.1M (+27%).
- Full-year 2024 revenue guidance raised to $788-798M, up $13M from prior $775-785M range.
- Management cites strong execution and sequential US revenue growth acceleration.
- Complete Q2 results and earnings call scheduled for August 6, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1609550/000160955024000034/0001609550-24-000034-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1609550/000160955024000034/insp-20240729.htm
  HTML page:      https://secwatch.observer/filing/0001609550-24-000034

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer